Roundtable Discussion: Reviewing the Next Generation of RNA Technologies as an Alternative Candidate for Use in Cancer Vaccines

Time: 11:30 am
day: Conference Day One


  • Revealing how sa-RNA is capable of inducing a strong immune response in the body allowing it to be an ideal candidate for use in cancer vaccines
  • Showing how circular-RNA has been found to be more stable and resistant to degradation than other forms of RNA
  • Investigating how si-RNA is capable of silencing specific genes that are involved in cancer growth and metastasis which can help to slow or even stop the growth of cancer cells